68135-673 : Palynziq 20 mg/ml Subcutaneous Injection, Solution


NDC68135-673
Labeler: Biomarin Pharmaceutical Inc.
Product Type: Human Prescription Drug
Drug Name:  Palynziq
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761079
Rev. Date: 


NDC Package Codes:

  • 68135-673-40: 1 SYRINGE IN 1 CARTON (68135‑673‑40) > 1 ML IN 1 SYRINGE (68135‑673‑39)
  • 68135-673-45: 10 SYRINGE IN 1 CARTON (68135‑673‑45) > 1 ML IN 1 SYRINGE (68135‑673‑39)

Active Ingredients:

  • Pegvaliase

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Phenylalanine Metabolizing Enzyme [EPC]
  • Phenylalanine Ammonia-Lyase [CS]

Related Products:

Based on records with the same trade name.
  • 68135-058 Palynziq 2.5 mg/.5ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.
  • 68135-756 Palynziq 10 mg/.5ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68135-673 QR Code

< Prev: 68135-482Next: 68135-756 >




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.